Members |
acceptabilityId |
p-phenylenediamine-containing product |
Preferred (foundation metadata concept) |
p-tert-Butylphenol |
Preferred (foundation metadata concept) |
p-tert-Butylphenol (substance) |
Preferred (foundation metadata concept) |
p-tert-butyl phenol formaldehyde resin |
Acceptable (foundation metadata concept) |
p-tert-butylphenol |
Preferred (foundation metadata concept) |
p-tert-butylphenol (substance) |
Preferred (foundation metadata concept) |
p-tert-butylphenol only product |
Preferred (foundation metadata concept) |
p-tert-butylphenol-containing product |
Preferred (foundation metadata concept) |
p-tert-butyltoluene |
Preferred (foundation metadata concept) |
p-tert-butyltoluene (substance) |
Preferred (foundation metadata concept) |
p-tertiary-butylphenol formaldehyde resin |
Acceptable (foundation metadata concept) |
p-xylene |
Acceptable (foundation metadata concept) |
p.m. serum specimen |
Preferred (foundation metadata concept) |
p.m. serum specimen (specimen) |
Preferred (foundation metadata concept) |
p.m. specimen |
Preferred (foundation metadata concept) |
p.m. specimen (specimen) |
Preferred (foundation metadata concept) |
p.m. trough specimen |
Preferred (foundation metadata concept) |
p.m. trough specimen |
Preferred (foundation metadata concept) |
p.m. trough specimen (qualifier value) |
Preferred (foundation metadata concept) |
p.m. trough specimen (specimen) |
Preferred (foundation metadata concept) |
p.p. - Post-prandial |
Acceptable (foundation metadata concept) |
p1 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
p110-delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency |
Acceptable (foundation metadata concept) |
p150,95 |
Acceptable (foundation metadata concept) |
p2 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
p27 (cyclin dependent kinase inhibitor) Ag |
Preferred (foundation metadata concept) |
p27 (cyclin dependent kinase inhibitor) antigen |
Acceptable (foundation metadata concept) |
p4 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
p40 |
Acceptable (foundation metadata concept) |
pCO2 - Partial pressure of carbon dioxide in blood |
Acceptable (foundation metadata concept) |
pH |
Acceptable (foundation metadata concept) |
pH |
Acceptable (foundation metadata concept) |
pH - finding |
Preferred (foundation metadata concept) |
pH - observation |
Acceptable (foundation metadata concept) |
pH measurement |
Preferred (foundation metadata concept) |
pH measurement (procedure) |
Preferred (foundation metadata concept) |
pH measurement, arterial |
Preferred (foundation metadata concept) |
pH measurement, arterial (procedure) |
Preferred (foundation metadata concept) |
pH measurement, body fluid |
Preferred (foundation metadata concept) |
pH measurement, body fluid (procedure) |
Preferred (foundation metadata concept) |
pH measurement, vaginal fluid |
Preferred (foundation metadata concept) |
pH measurement, vaginal fluid (procedure) |
Preferred (foundation metadata concept) |
pH measurement, venous |
Preferred (foundation metadata concept) |
pH measurement, venous (procedure) |
Preferred (foundation metadata concept) |
pH meter |
Preferred (foundation metadata concept) |
pH meter (physical object) |
Preferred (foundation metadata concept) |
pH monitoring capsule |
Preferred (foundation metadata concept) |
pH monitoring capsule (physical object) |
Preferred (foundation metadata concept) |
pH observations |
Preferred (foundation metadata concept) |
pH observations (finding) |
Preferred (foundation metadata concept) |
pH of sample |
Acceptable (foundation metadata concept) |
pH of stool |
Acceptable (foundation metadata concept) |
pH pattern |
Preferred (foundation metadata concept) |
pH pattern (qualifier value) |
Preferred (foundation metadata concept) |
pH profile |
Acceptable (foundation metadata concept) |
pH profile measurement |
Preferred (foundation metadata concept) |
pH profile measurement (procedure) |
Preferred (foundation metadata concept) |
pH reflux test |
Preferred (foundation metadata concept) |
pH reflux test (procedure) |
Preferred (foundation metadata concept) |
pH, combined acid measurement |
Preferred (foundation metadata concept) |
pH, combined acid measurement (procedure) |
Preferred (foundation metadata concept) |
pH, free acid measurement |
Preferred (foundation metadata concept) |
pH, free acid measurement (procedure) |
Preferred (foundation metadata concept) |
pH, total acid measurement |
Preferred (foundation metadata concept) |
pH, total acid measurement (procedure) |
Preferred (foundation metadata concept) |
pL |
Preferred (foundation metadata concept) |
pM |
Acceptable (foundation metadata concept) |
pM category |
Preferred (foundation metadata concept) |
pM category |
Preferred (foundation metadata concept) |
pM category (observable entity) |
Preferred (foundation metadata concept) |
pM category (tumor staging) |
Preferred (foundation metadata concept) |
pM category finding |
Preferred (foundation metadata concept) |
pM category finding (finding) |
Preferred (foundation metadata concept) |
pM0 category |
Preferred (foundation metadata concept) |
pM0 category (finding) |
Preferred (foundation metadata concept) |
pM0 stage |
Acceptable (foundation metadata concept) |
pM0: No distant metastasis |
Acceptable (foundation metadata concept) |
pM0: No distant metastasis (breast) |
Preferred (foundation metadata concept) |
pM0: No distant metastasis (breast) (finding) |
Preferred (foundation metadata concept) |
pM0: No distant metastasis from breast tumour |
Acceptable (foundation metadata concept) |
pM1 |
Preferred (foundation metadata concept) |
pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) |
Preferred (foundation metadata concept) |
pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) (finding) |
Preferred (foundation metadata concept) |
pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) |
Preferred (foundation metadata concept) |
pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) (finding) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) (finding) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) (finding) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) (finding) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) |
Preferred (foundation metadata concept) |
pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) (finding) |
Preferred (foundation metadata concept) |
pM1 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
pM1 category |
Preferred (foundation metadata concept) |
pM1 category (finding) |
Preferred (foundation metadata concept) |
pM1 stage |
Acceptable (foundation metadata concept) |
pM1: Distant metastasis |
Acceptable (foundation metadata concept) |
pM1: Distant metastasis (breast) |
Preferred (foundation metadata concept) |
pM1: Distant metastasis (breast) (finding) |
Preferred (foundation metadata concept) |
pM1: Distant metastasis from breast tumour |
Acceptable (foundation metadata concept) |